Literature DB >> 23431168

Reactive astrocytes secrete lcn2 to promote neuron death.

Fangfang Bi1, Cao Huang, Jianbin Tong, Guang Qiu, Bo Huang, Qinxue Wu, Fang Li, Zuoshang Xu, Robert Bowser, Xu-Gang Xia, Hongxia Zhou.   

Abstract

Glial reaction is a common feature of neurodegenerative diseases. Recent studies have suggested that reactive astrocytes gain neurotoxic properties, but exactly how reactive astrocytes contribute to neurotoxicity remains to be determined. Here, we identify lipocalin 2 (lcn2) as an inducible factor that is secreted by reactive astrocytes and that is selectively toxic to neurons. We show that lcn2 is induced in reactive astrocytes in transgenic rats with neuronal expression of mutant human TAR DNA-binding protein 43 (TDP-43) or RNA-binding protein fused in sarcoma (FUS). Therefore, lcn2 is induced in activated astrocytes in response to neurodegeneration, but its induction is independent of TDP-43 or FUS expression in astrocytes. We found that synthetic lcn2 is cytotoxic to primary neurons in a dose-dependent manner, but is innocuous to astrocytes, microglia, and oligodendrocytes. Lcn2 toxicity is increased in neurons that express a disease gene, such as mutant FUS or TDP-43. Conditioned medium from rat brain slice cultures with neuronal expression of mutant TDP-43 contains abundant lcn2 and is toxic to primary neurons as well as neurons in cultured brain slice from WT rats. Partial depletion of lcn2 by immunoprecipitation reduced conditioned medium-mediated neurotoxicity. Our data indicate that reactive astrocytes secrete lcn2, which is a potent neurotoxic mediator.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23431168      PMCID: PMC3593910          DOI: 10.1073/pnas.1218497110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.

Authors:  Francesco Paolo Di Giorgio; Monica A Carrasco; Michelle C Siao; Tom Maniatis; Kevin Eggan
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

3.  Genomic analysis of reactive astrogliosis.

Authors:  Jennifer L Zamanian; Lijun Xu; Lynette C Foo; Navid Nouri; Lu Zhou; Rona G Giffard; Ben A Barres
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

4.  Acute hippocampal slice preparation and hippocampal slice cultures.

Authors:  Pamela J Lein; Christopher D Barnhart; Isaac N Pessah
Journal:  Methods Mol Biol       Date:  2011

5.  Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.

Authors:  Seiji Okada; Masaya Nakamura; Hiroyuki Katoh; Tamaki Miyao; Takuya Shimazaki; Ken Ishii; Junichi Yamane; Akihiko Yoshimura; Yukihide Iwamoto; Yoshiaki Toyama; Hideyuki Okano
Journal:  Nat Med       Date:  2006-06-18       Impact factor: 53.440

6.  Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.

Authors:  Cao Huang; Jianbin Tong; Fangfang Bi; Hongxia Zhou; Xu-Gang Xia
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

7.  Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.

Authors:  P F Behrens; P Franz; B Woodman; K S Lindenberg; G B Landwehrmeyer
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

8.  Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.

Authors:  Cao Huang; Jianbin Tong; Fangfang Bi; Qinxue Wu; Bo Huang; Hongxia Zhou; Xu-Gang Xia
Journal:  Hum Mol Genet       Date:  2012-07-23       Impact factor: 6.150

9.  SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.

Authors:  D Trotti; A Rolfs; N C Danbolt; R H Brown; M A Hediger
Journal:  Nat Neurosci       Date:  1999-05       Impact factor: 24.884

10.  Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease.

Authors:  Angelo C Lepore; Britta Rauck; Christine Dejea; Andrea C Pardo; Mahendra S Rao; Jeffrey D Rothstein; Nicholas J Maragakis
Journal:  Nat Neurosci       Date:  2008-10-19       Impact factor: 24.884

View more
  120 in total

Review 1.  Biomaterial Approaches to Modulate Reactive Astroglial Response.

Authors:  Jonathan M Zuidema; Ryan J Gilbert; Manoj K Gottipati
Journal:  Cells Tissues Organs       Date:  2018-12-05       Impact factor: 2.481

2.  Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes.

Authors:  Nuno J Lamas; Alejandro D Garcia; Laurent Roybon; Eun Ju Yang; Rita Sattler; Vernice J Lewis; Yoon A Kim; C Alan Kachel; Jeffrey D Rothstein; Serge Przedborski; Hynek Wichterle; Christopher E Henderson
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

3.  TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes.

Authors:  Thomas J LaRocca; Andrea Mariani; Linda R Watkins; Christopher D Link
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

4.  Lipocalin 2 modulates the cellular response to amyloid beta.

Authors:  S D Mesquita; A C Ferreira; A M Falcao; J C Sousa; T G Oliveira; M Correia-Neves; N Sousa; F Marques; J A Palha
Journal:  Cell Death Differ       Date:  2014-05-23       Impact factor: 15.828

Review 5.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

6.  Profiling the genes affected by pathogenic TDP-43 in astrocytes.

Authors:  Cao Huang; Bo Huang; Fangfang Bi; Linda H Yan; Jianbin Tong; Jufang Huang; Xu-Gang Xia; Hongxia Zhou
Journal:  J Neurochem       Date:  2014-02-09       Impact factor: 5.372

7.  Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment.

Authors:  Amanda M Haidet-Phillips; Laurent Roybon; Sarah K Gross; Alisha Tuteja; Christopher J Donnelly; Jean-Philippe Richard; Myungsung Ko; Alex Sherman; Kevin Eggan; Christopher E Henderson; Nicholas J Maragakis
Journal:  Stem Cells Transl Med       Date:  2014-03-06       Impact factor: 6.940

8.  Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.

Authors:  Youngpyo Nam; Jong-Heon Kim; Minchul Seo; Jae-Hong Kim; Myungwon Jin; Sangmin Jeon; Jung-wan Seo; Won-Ha Lee; So Jin Bing; Youngheun Jee; Won Kee Lee; Dong Ho Park; Hyun Kook; Kyoungho Suk
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

9.  Ezrin expression and cell survival regulation in colorectal cancer.

Authors:  Premila D Leiphrakpam; Ashwani Rajput; Michelle Mathiesen; Ekta Agarwal; Audrey J Lazenby; Chandrakanth Are; Michael G Brattain; Sanjib Chowdhury
Journal:  Cell Signal       Date:  2014-01-22       Impact factor: 4.315

10.  Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats.

Authors:  Jianbin Tong; Cao Huang; Fangfang Bi; Qinxue Wu; Bo Huang; Xionghao Liu; Fang Li; Hongxia Zhou; Xu-Gang Xia
Journal:  EMBO J       Date:  2013-05-28       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.